Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)-Reference-Cited by-同舟云学术

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)

Published:2020-04 Issue:4 Volume:61 Page:647-656
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Rudà Roberta¹^ORCID,Houillier Caroline²,Maschio Marta³^ORCID,Reijneveld Jaap C.⁴⁵,Hellot Scarlett⁶,De Backer Marc⁷,Chan Jane⁸,Joeres Lars⁶,Leunikava Iryna⁶,Glas Martin⁹,Grant Robin¹⁰^ORCID

Affiliation:

1. Department of Neuro‐Oncology City of Health and Science and University of Turin Turin Italy

2. AP-HP, Sorbonne Université IHU, ICM Public Hospital Network of Paris Service de Neurologie 2-Mazarin Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix Paris France

3. Center for Tumor‐Related Epilepsy UOSD Neuro‐Oncology IRCCS Regina Elena National Cancer Institute Rome Italy

4. Amsterdam UMC Amsterdam The Netherlands

5. Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede The Netherlands

6. UCB Pharma Monheim am Rhein Germany

7. UCB Pharma Brussels Belgium

8. UCB Pharma Slough UK

9. Division of Clinical Neuro‐oncology Department of Neurology West German Cancer Center and German Cancer Consortium Partner SiteEssen University HospitalUniversity of Duisburg‐Essen Essen Germany

10. Department of Clinical Neurosciences Royal Infirmary of Edinburgh Edinburgh UK

Funder

UCB

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16486

Reference39 articles.

1. Brain Tumors

2. Brain Tumor-Related Epilepsy